Inadequate Nutrient Intake in Patients with Celiac Disease: Results from a German Dietary SurveyMartin J.a, c · Geisel T.a, c · Maresch C.a, c · Krieger K.b · Stein J.a, b
aCrohn Colitis Center Rhein-Main and bSachsenhausen Hospital, Frankfurt, and cInstitute of Nutritional Science, University of Giessen, Giessen, Germany
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Currently, the only treatment for celiac disease (CD) is a lifelong gluten-free diet (GFD). Research has been carried out in various countries into the nutritional adequacy of the GFD in terms of macro- and micronutrients, mostly presenting conflicting results. However, no data for Germany are available to date. Aim: To elucidate the nutritional composition of a GFD and to compare it with non-GFD in a representative German non-CD population. Methods and Patients: A total of 1,000 patients who were members of the German Celiac Society (DZG) were invited to fill out a prospective 7-day food diary and a questionnaire. Data from 88 patients aged 14-80 years were analyzed and compared to the DACH reference values and to data from the German National Diet and Nutrition Survey (NVS II). Results: No significant difference was observed for the intake of energy and macronutrients in male celiac patients compared to the NVS II. Only the fiber intake of male patients was significantly lower than that of the general population. Female patients, however, showed a significantly higher fat intake, but lower carbohydrate consumption. The average daily micronutrient intake of male and female patients, specifically of vitamin B1, B2, B6, folic acid, magnesium and iron, was significantly lower in celiac patients compared to the NVS II. Conclusion: This study reveals inadequate nutrient intake by male and female celiac patients in Germany. Based on our findings, regular (laboratory) monitoring of celiac patients should be recommended.
© 2013 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.